WHY EVITAROL

EVITAROL is formulated with actives that are based on a derivative used in other countries: most specifically, Cuba and India. With these countrys’ prophylactic approach to Covid a reduction in infection rates are reduced. A comparative perspective shows, most recent figures as of August 6th 2021: 

 

US reports 108,973 total cases per million population with 1,897 deaths per million of the population.

 

Canada reports 37,691 cases per million of population with a total of 691 deaths per million of the population.

 

India reports 22,839 cases per million of population with a total of  306 deaths per million of the population.

 

Cuba reports 38,079 cases per million of population, with a total of  281 deaths per million of the population. 

 

Cuba is using a similar homeopathic for prevention first introduced in April 2020 shortly after WHO announced Covid-19 a pandemic.

 

As previously published, both Cuba and India have reported using a homeopathic remedy with ingredients similar to EVITAROL as an approach to managing COVID 19. The numbers in comparison to other countries show a greater less per population infection rate. We have investigated the findings, and created an immune system based, respiratory infection focused, antibody resistant compounded formula of identifiably proven ingredients to create a novel remedy to approach the virus and similar respiratory infection. 

 

This is EVITAROL.